0001192482-19-000034.txt : 20190123 0001192482-19-000034.hdr.sgml : 20190123 20190123160639 ACCESSION NUMBER: 0001192482-19-000034 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190118 FILED AS OF DATE: 20190123 DATE AS OF CHANGE: 20190123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Celano Michael CENTRAL INDEX KEY: 0001377582 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36329 FILM NUMBER: 19537485 MAIL ADDRESS: STREET 1: 220 EAST FIRST STREET CITY: BETHLEHEM STATE: PA ZIP: 18015 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Recro Pharma, Inc. CENTRAL INDEX KEY: 0001588972 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261523233 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 490 LAPP ROAD CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: (484) 395-2400 MAIL ADDRESS: STREET 1: 490 LAPP ROAD CITY: MALVERN STATE: PA ZIP: 19355 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2019-01-18 0001588972 Recro Pharma, Inc. REPH 0001377582 Celano Michael C/O RECRO PHARMA, INC. 490 LAPP ROAD MALVERN PA 19355 0 1 0 0 Chief Operating Officer Common Stock 2019-01-18 4 A 0 12672 0 A 39445 D Common Stock 2019-01-18 4 M 0 6400 A 45845 D Common Stock 2019-01-18 4 F 0 1782 7.99 D 44063 D Employee Stock Option (right to buy) 7.99 2019-01-18 4 A 0 60592 0 A 2029-01-18 Common Stock 60592 60592 D Restricted Stock Units 2019-01-18 4 M 0 6400 0 D Common Stock 6400 12800 D All of the shares of common stock are represented by restricted stock units that will vest in four equal annual installments beginning January 18, 2020, subject to continued employment with the Company. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date. Restricted stock units convert into common stock on a one-for-one basis. Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.. The stock option vests in equal monthly installments over 48 months, beginning on the date that is one month from the date of grant, subject to continued employment with the Company. On January 18, 2017, the reporting person was granted 25,600 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. /s/ Ryan D. Lake, as attorney-in-fact 2019-01-22